Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT04258397
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose other
- Phase
- Phase 2
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT04258397
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT04258397. Randomized; triple masking; primary purpose other. Start 2020-10-26 (actual); primary completion 2024-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease
- Acronym
- TOP-CKD
- Condition
- Chronic Kidney Disease
- Intervention (Drug)
- Pirfenidone
- Intervention (Drug)
- matching placebo
- Lead sponsor
- Veterans Medical Research Foundation
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator
- San Diego Veterans Healthcare System
- Collaborator
- University of California, San Diego
- Collaborator
- University of California, San Francisco
- Collaborator
- Genentech, Inc.
Record details
- Record id
cardio:ct-nct04258397- Content hash
9357a94ffb32deeef9d8e50c8505220d2c246f74af863ac2b70a432ec61220b5